{"favorite_id": 3803, "calc_type": "calculator", "dosing": false, "full_title_en": "MAGGIC Risk Calculator for Heart Failure", "short_title_en": "MAGGIC Risk Calculator for HF", "medium_description_en": "Estimates 1- and 3- year mortality in heart failure.", "short_description_en": "Estimates 1- and 3- year heart failure mortality.", "before_use": "", "instructions_en": "<p>Use in adult patients (\u226518 years). Use with caution in patients with reduced ejection fraction (not yet externally validated in this population).</p>", "purpose_en": ["Prognosis"], "disease_en": ["Congestive Heart Failure", "Heart Failure"], "specialty_en": ["Cardiology"], "chief_complaint_en": ["Chest Pain", "Dyspnea", "Extremity Edema", "Shortness of Breath", "Weight Loss/Gain"], "system_en": ["Cardiac"], "search_abbreviation_en": ["Hf", "heart failure", "magic", "mortality", "survival", "EF", "ejection", "fraction", "ejection fraction", "CHF", "congestive heart failure"], "slug": "maggic-risk-calculator-heart-failure", "seo": {"meta_description_en": "The MAGGIC Risk Calculator for Heart Failure estimates 1- and 3- year mortality in patients with heart failure.", "keywords_en": "Magicc, magicc score, magicc calc, maggic, maggicc, magic prognosis, magicc Hf, heart failure, magic, mortality, survival, EF, ejection, fraction "}, "content": {"how_to_use": {"use_case_en": "<p>Adult patients with heart failure and preserved EF.</p>", "pearls_pitfalls_en": "<ul> <li>The Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC) Risk Calculator assigns an integer score based on heart failure risk factors to predict mortality at 1 and 3 years.</li> <li>Can be used in heart failure patients with reduced or preserved ejection fraction (EF).</li> <li>Not yet externally validated for patients with reduced EF.</li> <li>Excludes biomarkers known to correlate with mortality, such as B-type natriuretic peptide.</li> </ul>", "why_use_en": "<p>Heart failure with preserved EF has significant mortality and is rising in incidence. Predictive models to stratify risk for these patients are necessary.</p>"}, "next_steps": {"advice_en": "<p>Consider individualized choice of pharmacotherapy (e.g. beta blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers) for treatment of heart failure based on score.</p>", "management_en": "", "critical_actions_en": ""}, "about": {"formula_en": "<p>Addition of selected points.</p>", "more_info_en": "<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Risk Factor</strong></td>\n<td><strong>Points</strong></td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p>Male</p>\n<p>Smoker</p>\n<p>Diabetic</p>\n<p>COPD</p>\n<p>Heart failure first diagnosed &ge;18 months ago</p>\n<p>Not on beta blocker</p>\n<p>Not on ACE-I/ARB</p>\n</td>\n<td>\n<p>+1</p>\n<p>+1</p>\n<p>+3</p>\n<p>+2</p>\n<p>+2</p>\n<p>+3</p>\n<p>+1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ejection fraction (EF)</p>\n</td>\n<td>\n<p>&lt;20</p>\n<p>20-24</p>\n<p>25-29</p>\n<p>30-34</p>\n<p>35-39</p>\n<p>&ge;40</p>\n</td>\n<td>\n<p>+7</p>\n<p>+6</p>\n<p>+5</p>\n<p>+3</p>\n<p>+2</p>\n<p>+0</p>\n</td>\n</tr>\n<tr>\n<td>NYHA class</td>\n<td>\n<p>1</p>\n<p>2</p>\n<p>3</p>\n<p>4</p>\n</td>\n<td>\n<p>+0</p>\n<p>+2</p>\n<p>+6</p>\n<p>+8&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Creatinine*</td>\n<td>\n<p>&nbsp;&lt;90</p>\n<p>90-109</p>\n<p>110-129</p>\n<p>130-149</p>\n<p>150-169</p>\n<p>170-209</p>\n<p>210-249</p>\n<p>&ge;250</p>\n</td>\n<td>\n<p>+0</p>\n<p>+1</p>\n<p>+2</p>\n<p>+3</p>\n<p>+4</p>\n<p>+5</p>\n<p>+6</p>\n<p>+8&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>BMI&nbsp;</td>\n<td>\n<p>&lt;15</p>\n<p>15-19</p>\n<p>20-24</p>\n<p>&nbsp;25-29</p>\n<p>&ge;30</p>\n</td>\n<td>\n<p>+6</p>\n<p>+5</p>\n<p>+3</p>\n<p>+2</p>\n<p>+0&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Extra for&nbsp;systolic BP (mm Hg) if EF &lt;30</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>&lt;110</p>\n<p>110-119</p>\n<p>120-129</p>\n<p>130-139</p>\n<p>140-149</p>\n<p>&ge;150</p>\n</td>\n<td>\n<p>+5</p>\n<p>+4</p>\n<p>+3</p>\n<p>+2</p>\n<p>+1</p>\n<p>+0&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Extra for&nbsp;systolic BP (mm Hg) if EF 30-39</td>\n<td>\n<p>&lt;110</p>\n<p>110-119</p>\n<p>120-129</p>\n<p>130-139</p>\n<p>140-149</p>\n<p>&ge;150</p>\n</td>\n<td>\n<p>+3</p>\n<p>+2</p>\n<p>+1</p>\n<p>+1</p>\n<p>+0</p>\n<p>+0</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;&nbsp;Extra for&nbsp;systolic BP (mm Hg) if EF &ge;40</td>\n<td>\n<p>&nbsp;&lt;110</p>\n<p>110-119</p>\n<p>120-129</p>\n<p>130-139</p>\n<p>140-149</p>\n<p>&ge;150</p>\n</td>\n<td>\n<p>+2</p>\n<p>+1</p>\n<p>+1</p>\n<p>+0</p>\n<p>+0</p>\n<p>+0&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Extra for age (years) if EF &lt;30</td>\n<td>\n<p>&lt;55</p>\n<p>55-59</p>\n<p>60-64</p>\n<p>65-69</p>\n<p>70-74</p>\n<p>75-79</p>\n<p>&ge;80</p>\n</td>\n<td>\n<p>+0</p>\n<p>+1</p>\n<p>+2</p>\n<p>+4</p>\n<p>+6</p>\n<p>+8</p>\n<p>+10</p>\n</td>\n</tr>\n<tr>\n<td>Extra for age (years) if EF 30-39</td>\n<td>\n<p>&lt;55</p>\n<p>55-59</p>\n<p>60-64</p>\n<p>65-69</p>\n<p>70-74</p>\n<p>75-79</p>\n<p>&ge;80</p>\n</td>\n<td>\n<p>+0</p>\n<p>+2</p>\n<p>+4</p>\n<p>+6</p>\n<p>+8</p>\n<p>+10</p>\n<p>+13&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Extra for age (years) if EF &ge;40</td>\n<td>\n<p>&lt;55</p>\n<p>55-59</p>\n<p>60-64</p>\n<p>65-69</p>\n<p>70-74</p>\n<p>75-79</p>\n<p>&ge;80</p>\n</td>\n<td>\n<p>+0</p>\n<p>+3</p>\n<p>+5</p>\n<p>+7</p>\n<p>+9</p>\n<p>+12</p>\n<p>+15&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>*Note: while this score uses creatinine as a proxy for renal function, eGFR is generally considered a more accurate indicator.</p>", "evidence_based_medicine_en": "<p>The Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC) Risk Calculator was developed by an international group of researchers let by <a href=\"http://eurheartj.oxfordjournals.org/content/early/2012/10/23/eurheartj.ehs337\" target=\"_blank\">Pocock et al</a> based on a database of 39,372 patients from 30 cohort studies (of which 6 were randomized clinical trials, accounting for approximately 24,000 patients).</p> <p>A Poisson regression model was built to identify 13 risk factors contributing to mortality in patients with heart failure. Comparisons of observed and expected 3-year mortality rates across all 30 studies showed acceptable goodness-of-fit. Two separate models were used for preserved versus reduced ejection fraction (EF).</p> <p>A subsequent study by <a href=\"http://circimaging.ahajournals.org/content/9/3/e003754.long\" target=\"_blank\">Freed et al (2016)</a> showed that for 308 patients with heart failure with preserved EF, a higher MAGGIC risk score was associated with more adverse events.</p> <p>The data have not yet been externally validated for reduced EF.</p>", "references_list": {"Original/Primary Reference": [{"href": "http://eurheartj.oxfordjournals.org/content/early/2012/10/23/eurheartj.ehs337", "text": "Pocock SJ et al. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J. 2013 May;34(19):1404-13. doi: 10.1093/eurheartj/ehs337. Epub 2012 Oct 24."}], "Other References": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/21821849", "text": "Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J. 2012 Jul;33(14):1750-7. doi: 10.1093/eurheartj/ehr254. Epub 2011 Aug 6."}, {"href": "https://www.ncbi.nlm.nih.gov/pubmed/26385583 ", "text": "Nanayakkara S, Kaye DM. Management of heart failure with preserved ejection fraction: a review. Clin Ther. 2015 Oct 1;37(10):2186-98. doi: 10.1016/j.clinthera.2015.08.005. Epub 2015 Sep 16."}, {"href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089693/", "text": "Chapter 1: Definition and classification of CKD. Kidney Int Suppl (2011). 2013;3(1):19-62."}], "Validation": [{"href": "http://circimaging.ahajournals.org/content/9/3/e003754.long ", "text": "Freed BH, Daruwalla V, Cheng JY, Aguilar FG, Beussink L, Choi A, Klein DA, Dixon D, Baldridge A, Rasmussen-Torvik LJ, Maganti K, Shah SJ. Prognostic Utility and Clinical Significance of Cardiac Mechanics in Heart Failure With Preserved Ejection Fraction: Importance of Left Atrial Strain. Circ Cardiovasc Imaging. 2016 Mar;9(3). pii: e003754. doi: 10.1161/CIRCIMAGING.115.003754."}], "Clinical Practice Guidelines": [{"href": "", "text": ""}], "Manufacturer Website": [{"href": "", "text": ""}], "Outcomes": [{"href": "", "text": ""}]}}, "contributor": {"expert_name": []}, "reviewer": {"expert_name": []}, "creator": [{"name": "Dr. Stuart Pocock", "creator_info": {"about_en": "<p>Stuart Pocock, PhD, is a professor of medical statistics at the London School of Hygiene and Tropical Medicine. Dr. Pocock is a director of multiple research groups investigating epidemiology and pharmacoepidemiology. He has published many papers on major trials he has conducted, especially in cardiovascular disease.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-stuart-pocock.jpeg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Pocock+SJ%5BAuthor%5D"}}], "related_resources": {"mdcalc_rating": {"evidence": "", "clinical": "", "popularity": ""}, "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "textbox", "label_en": "Age", "name": "age", "unit": "age_adult", "conditionality": "", "optional": false, "unit_info": {"name": "Age", "conversion": 1, "error_min": 18, "error_max": 110, "warn_min": 18, "warn_max": 110, "normal_max_si": 0, "normal_min_si": 0, "normal_min_us": 0, "units_si": "years", "units_us": "years"}}, {"type": "textbox", "label_en": "Ejection Fraction", "name": "ef", "unit": "neut", "conditionality": "", "optional": false, "unit_info": {"name": "% Neutrophils", "conversion": 1, "error_min": -0.01, "error_max": 100.01, "warn_min": 0, "warn_max": 100, "normal_max_si": 0, "normal_min_si": 0, "normal_min_us": 0, "units_si": "%", "units_us": "%"}}, {"type": "textbox", "label_en": "sBP", "name": "sbp", "unit": "sbp", "conditionality": "", "optional": false, "unit_info": {"name": "Systolic BP", "conversion": 1, "error_min": 30, "error_max": 300, "warn_min": 40, "warn_max": 250, "normal_max_si": 120, "normal_min_si": 100, "normal_min_us": 100, "units_si": "mm Hg", "units_us": "mm Hg", "normal_max_us": 120}}, {"type": "textbox", "label_en": "<calculator id='29'>BMI</calculator>", "name": "bmi", "unit": "BMI", "conditionality": "", "optional": false, "unit_info": {"name": "Body Mass Index", "conversion": 1, "error_min": 0, "error_max": 50, "warn_min": 10, "warn_max": 30, "normal_max_si": 25, "normal_min_si": 20, "normal_min_us": 20, "units_si": "kg/m\u00b2", "units_us": "kg/m\u00b2", "normal_max_us": 25}}, {"type": "textbox", "label_en": "Creatinine", "name": "cr", "unit": "cr", "conditionality": "", "optional": false, "tips_en": "Note: while this score uses creatinine as a proxy for renal function, eGFR is generally considered a more accurate indicator", "unit_info": {"name": "Creatinine", "conversion": 88.4, "error_min": 0.01, "error_max": 40, "warn_min": 0, "warn_max": 10, "normal_max_si": 115, "normal_min_si": 62, "normal_min_us": 0.7, "units_si": "\u00b5mol/L", "units_us": "mg/dL", "normal_max_us": 1.3}}, {"type": "radio", "label_en": "NYHA Class", "name": "nyha", "options": [{"label": "Class I", "value": 0}, {"label": "Class II", "value": 2}, {"label": "Class III", "value": 6}, {"label": "Class IV", "value": 8}], "conditionality": "", "show_points": true, "optional": false}, {"type": "toggle", "label_en": "Gender", "name": "sex", "options": [{"label": "Female", "value": 0}, {"label": "Male", "value": 1}], "conditionality": "", "show_points": true, "optional": false}, {"type": "toggle", "label_en": "Current smoker", "name": "smoke", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "conditionality": "", "show_points": true, "default": 0, "optional": false}, {"type": "toggle", "label_en": "Diabetes", "name": "dm", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 3}], "conditionality": "", "show_points": true, "default": 0, "optional": false}, {"type": "toggle", "label_en": "COPD", "name": "copd", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 2}], "conditionality": "", "show_points": true, "default": 0, "optional": false}, {"type": "toggle", "label_en": "Heart failure first diagnosed \u226518 months ago", "name": "hfdx", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 2}], "conditionality": "", "show_points": true, "default": 0, "optional": false}, {"type": "toggle", "label_en": "Beta blocker", "name": "bb", "options": [{"label": "No", "value": 3}, {"label": "Yes", "value": 0}], "conditionality": "", "show_points": true, "default": 1, "optional": false}, {"type": "toggle", "label_en": "ACEi/ARB", "name": "ace", "options": [{"label": "No", "value": 1}, {"label": "Yes", "value": 0}], "conditionality": "", "show_points": true, "default": 1, "optional": false}], "md5": "faf0523a5815321f7def0f0c07d20a1e", "related_calcs": [{"calcId": 3987, "short_title_en": "NYHA Heart Failure Classification", "slug": "new-york-heart-association-nyha-functional-classification-heart-failure"}, {"calcId": 3800, "short_title_en": "Framingham HF Criteria", "slug": "framingham-heart-failure-diagnostic-criteria"}, {"calcId": 3829, "short_title_en": "GWTG-HF Risk Score", "slug": "gwtg-heart-failure-risk-score"}]}